| Year |
Citation |
Score |
| 2023 |
Hickie IB, Iorfino F, Rohleder C, Song YJC, Nichles A, Zmicerevska N, Capon W, Guastella AJ, Leweke FM, Scott J, McGorry P, Mihalopoulos C, Killackey E, Chong MK, McKenna S, ... ... Koethe D, et al. EMPOWERED trial: protocol for a randomised control trial of digitally supported, highly personalised and measurement-based care to improve functional outcomes in young people with mood disorders. Bmj Open. 13: e072082. PMID 37821139 DOI: 10.1136/bmjopen-2023-072082 |
0.708 |
|
| 2023 |
Koethe D, Rohleder C, Kracht L, Leweke FM. Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental state. Frontiers in Psychiatry. 14: 1088459. PMID 36937734 DOI: 10.3389/fpsyt.2023.1088459 |
0.735 |
|
| 2022 |
Carpenter JS, Zmicerevska N, Crouse JJ, Nichles A, Garland A, Song YJC, Wilson C, Rohleder C, McHugh C, Leweke FM, Koethe D, Scott EM, Hickie IB. Effects of adjunctive brexpiprazole on sleep-wake and circadian parameters in youth with depressive disorders: study protocol for a clinical trial. Bmj Open. 12: e056298. PMID 36691133 DOI: 10.1136/bmjopen-2021-056298 |
0.707 |
|
| 2022 |
Couttas TA, Boost C, Pahlisch F, Sykorova EB, Leweke JE, Koethe D, Endepols H, Rohleder C, Leweke FM. Simultaneous Assessment of Serum Levels and Pharmacologic Effects of Cannabinoids on Endocannabinoids and -Acylethanolamines by Liquid Chromatography-Tandem Mass Spectrometry. Cannabis and Cannabinoid Research. PMID 35580134 DOI: 10.1089/can.2021.0181 |
0.691 |
|
| 2021 |
Nichles A, Zmicerevska N, Song YJC, Wilson C, McHugh C, Hamilton B, Crouse J, Rohleder C, Carpenter JS, Ho N, Hermens DF, Wray N, Scott J, Merikangas KR, Leweke FM, ... Koethe D, et al. Neurobiology Youth Follow-up Study: protocol to establish a longitudinal and prospective research database using multimodal assessments for current and past mental health treatment-seeking young people within an early intervention service. Bmj Open. 11: e044731. PMID 34145010 DOI: 10.1136/bmjopen-2020-044731 |
0.72 |
|
| 2021 |
Leweke FM, Rohleder C, Gerth CW, Hellmich M, Pukrop R, Koethe D. Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial. Frontiers in Pharmacology. 12: 614811. PMID 33995015 DOI: 10.3389/fphar.2021.614811 |
0.759 |
|
| 2021 |
Bien CG, Rohleder C, Mueller JK, Bien CI, Koethe D, Leweke FM. Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy Volunteers. Frontiers in Psychiatry. 12: 654602. PMID 33841216 DOI: 10.3389/fpsyt.2021.654602 |
0.77 |
|
| 2020 |
Woelfl T, Rohleder C, Mueller JK, Lange B, Reuter A, Schmidt AM, Koethe D, Hellmich M, Leweke FM. Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers. Frontiers in Psychiatry. 11: 576877. PMID 33304282 DOI: 10.3389/fpsyt.2020.576877 |
0.757 |
|
| 2020 |
Rohleder C, Song YJC, Crouse JJ, Davenport TA, Iorfino F, Hamilton B, Zmicerevska N, Nichles A, Carpenter JS, Tickell AM, Wilson C, Cross SP, Guastella AJ, Koethe D, Leweke FM, et al. Youth Mental Health Tracker: protocol to establish a longitudinal cohort and research database for young people attending Australian mental health services. Bmj Open. 10: e035379. PMID 32513883 DOI: 10.1136/Bmjopen-2019-035379 |
0.705 |
|
| 2019 |
Chadwick VL, Rohleder C, Koethe D, Leweke FM. Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humans. Current Opinion in Psychiatry. PMID 31714262 DOI: 10.1097/Yco.0000000000000562 |
0.705 |
|
| 2019 |
Hickie IB, Scott EM, Cross SP, Iorfino F, Davenport TA, Guastella AJ, Naismith SL, Carpenter JS, Rohleder C, Crouse JJ, Hermens DF, Koethe D, Markus Leweke F, Tickell AM, Sawrikar V, et al. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health. The Medical Journal of Australia. 211: S3-S46. PMID 31679171 DOI: 10.5694/Mja2.50383 |
0.657 |
|
| 2019 |
Hasan A, von Keller R, Friemel CM, Hall W, Schneider M, Koethe D, Leweke FM, Strube W, Hoch E. Cannabis use and psychosis: a review of reviews. European Archives of Psychiatry and Clinical Neuroscience. PMID 31563981 DOI: 10.1007/S00406-019-01068-Z |
0.515 |
|
| 2018 |
Grent-'t-Jong T, Gross J, Goense J, Wibral M, Gajwani R, Gumley AI, Lawrie SM, Schwannauer M, Schultze-Lutter F, Navarro Schröder T, Koethe D, Leweke FM, Singer W, Uhlhaas PJ. Resting-state gamma-band power alterations in schizophrenia reveal E/I-balance abnormalities across illness-stages. Elife. 7. PMID 30260771 DOI: 10.7554/Elife.37799 |
0.558 |
|
| 2018 |
Leweke FM, Mueller JK, Lange B, Fritze S, Topor CE, Koethe D, Rohleder C. Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention. Cns Drugs. PMID 30022465 DOI: 10.1007/S40263-018-0539-Z |
0.82 |
|
| 2018 |
Rohleder C, Koethe D, Fritze S, Topor CE, Leweke FM, Hirjak D. Neural correlates of binocular depth inversion illusion in antipsychotic-naïve first-episode schizophrenia patients. European Archives of Psychiatry and Clinical Neuroscience. PMID 29556734 DOI: 10.1007/S00406-018-0886-2 |
0.788 |
|
| 2018 |
Koethe D, Pahlisch F, Hellmich M, Rohleder C, Mueller JK, Meyer-Lindenberg A, Torrey EF, Piomelli D, Leweke FM. Familial Abnormalities of Endocannabinoid Signaling in Schizophrenia. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-26. PMID 29521179 DOI: 10.1080/15622975.2018.1449966 |
0.81 |
|
| 2017 |
Reuter AR, Mueller JK, Bumb JM, Rohleder C, Pahlisch F, Hanke F, Lange B, Koethe D, Schwarz E, Leweke FM. 570. Differential Association of Anandamide Levels with Binocular Depth Inversion Illusion Scores in Schizophrenia Biological Psychiatry. 81: S230-S231. DOI: 10.1016/J.Biopsych.2017.02.440 |
0.801 |
|
| 2016 |
Reuter AR, Bumb JM, Mueller JK, Rohleder C, Pahlisch F, Hanke F, Arens E, Leweke FM, Koethe D, Schwarz E. Association of Anandamide with altered Binocular Depth Inversion Illusion in Schizophrenia. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-17. PMID 27734750 DOI: 10.1080/15622975.2016.1246750 |
0.816 |
|
| 2014 |
Rivolta D, Castellanos NP, Stawowsky C, Helbling S, Wibral M, Grützner C, Koethe D, Birkner K, Kranaster L, Enning F, Singer W, Leweke FM, Uhlhaas PJ. Source-reconstruction of event-related fields reveals hyperfunction and hypofunction of cortical circuits in antipsychotic-naive, first-episode schizophrenia patients during Mooney face processing. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 5909-17. PMID 24760850 DOI: 10.1523/Jneurosci.3752-13.2014 |
0.581 |
|
| 2014 |
Schnell T, Koethe D, Krasnianski A, Gairing S, Schnell K, Daumann J, Gouzoulis-Mayfrank E. Ziprasidone versus clozapine in the treatment of dually diagnosed (DD) patients with schizophrenia and cannabis use disorders: a randomized study. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 23: 308-12. PMID 24628830 DOI: 10.1111/J.1521-0391.2014.12126.X |
0.467 |
|
| 2014 |
Schaefer C, Enning F, Mueller JK, Bumb JM, Rohleder C, Odorfer TM, Klosterkötter J, Hellmich M, Koethe D, Schmahl C, Bohus M, Leweke FM. Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders. European Archives of Psychiatry and Clinical Neuroscience. 264: 459-63. PMID 24253425 DOI: 10.1007/S00406-013-0470-8 |
0.75 |
|
| 2014 |
Herberth M, Rahmoune H, Schwarz E, Koethe D, Harris LW, Kranaster L, Witt SH, Spain M, Barnes A, Schmolz M, Leweke MF, Guest PC, Bahn S. Identification of a molecular profile associated with immune status in first-onset schizophrenia patients. Clinical Schizophrenia & Related Psychoses. 7: 207-15. PMID 23395839 DOI: 10.3371/Csrp.Hera.020113 |
0.454 |
|
| 2014 |
Leweke FM, Hellmich M, Pahlisch F, Kranaster L, Koethe D. MODULATION OF THE ENDOCANNABINOID SYSTEM AS A POTENTIAL NEW TARGET IN THE TREATMENT OF SCHIZOPHRENIA Schizophrenia Research. 153: S47. DOI: 10.1016/S0920-9964(14)70153-7 |
0.642 |
|
| 2014 |
Leweke FM, Kranaster L, Hoyer C, Neatby M, Haensel A, Gross S, Nolden B, Klosterkötter J, Emrich H, Koethe D. THE BINOCULAR DEPTH INVERSION ILLUSION TEST – A BASIC MEASURE OF PERCEPTUAL INTEGRATION Schizophrenia Research. 153: S39. DOI: 10.1016/S0920-9964(14)70128-8 |
0.582 |
|
| 2013 |
Sun L, Castellanos N, Grützner C, Koethe D, Rivolta D, Wibral M, Kranaster L, Singer W, Leweke MF, Uhlhaas PJ. Evidence for dysregulated high-frequency oscillations during sensory processing in medication-naïve, first episode schizophrenia. Schizophrenia Research. 150: 519-25. PMID 24016727 DOI: 10.1016/J.Schres.2013.08.023 |
0.369 |
|
| 2013 |
Ceccarini J, De Hert M, Van Winkel R, Peuskens J, Bormans G, Kranaster L, Enning F, Koethe D, Leweke FM, Van Laere K. Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia. Neuroimage. 79: 304-12. PMID 23624489 DOI: 10.1016/J.Neuroimage.2013.04.052 |
0.594 |
|
| 2012 |
Leweke FM, Piomelli D, Pahlisch F, Muhl D, Gerth CW, Hoyer C, Klosterkötter J, Hellmich M, Koethe D. Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Translational Psychiatry. 2: e94. PMID 22832859 DOI: 10.1038/Tp.2012.15 |
0.678 |
|
| 2012 |
Schwarz E, Guest PC, Rahmoune H, Harris LW, Wang L, Leweke FM, Rothermundt M, Bogerts B, Koethe D, Kranaster L, Ohrmann P, Suslow T, McAllister G, Spain M, Barnes A, et al. Identification of a biological signature for schizophrenia in serum. Molecular Psychiatry. 17: 494-502. PMID 21483431 DOI: 10.1038/Mp.2011.42 |
0.652 |
|
| 2012 |
Leweke FM, Koethe D, Pahlisch F, Hellmich M, Rohleder C, Meyer-Lindenberg A, Piomelli D. A TWIN STUDY ON ABNORMALITIES OF ENDOCANNABINOID FUNCTIONING IN SCHIZOPHRENIA AND BIPOLAR DISORDER Schizophrenia Research. 136: S26-S27. DOI: 10.1016/S0920-9964(12)70093-2 |
0.791 |
|
| 2011 |
Kranaster L, Koethe D, Hoyer C, Meyer-Lindenberg A, Leweke FM. Cerebrospinal fluid diagnostics in first-episode schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 261: 529-30. PMID 21298501 DOI: 10.1007/S00406-011-0193-7 |
0.656 |
|
| 2011 |
Schwarz E, Whitfield P, Nahnsen S, Wang L, Major H, Leweke FM, Koethe D, Lio P, Bahn S. Alterations of primary fatty acid amides in serum of patients with severe mental illness. Frontiers in Bioscience (Elite Edition). 3: 308-14. PMID 21196311 |
0.655 |
|
| 2011 |
Herberth M, Koethe D, Levin Y, Schwarz E, Krzyszton ND, Schoeffmann S, Ruh H, Rahmoune H, Kranaster L, Schoenborn T, Leweke MF, Guest PC, Bahn S. Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival. Proteomics. 11: 94-105. PMID 21182197 DOI: 10.1002/Pmic.201000291 |
0.359 |
|
| 2011 |
Herberth M, Koethe D, Cheng TM, Krzyszton ND, Schoeffmann S, Guest PC, Rahmoune H, Harris LW, Kranaster L, Leweke FM, Bahn S. Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients. Molecular Psychiatry. 16: 848-59. PMID 20585325 DOI: 10.1038/Mp.2010.71 |
0.657 |
|
| 2010 |
Schwarz E, Izmailov R, Spain M, Barnes A, Mapes JP, Guest PC, Rahmoune H, Pietsch S, Leweke FM, Rothermundt M, Steiner J, Koethe D, Kranaster L, Ohrmann P, Suslow T, et al. Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia. Biomarker Insights. 5: 39-47. PMID 20520744 DOI: 10.4137/Bmi.S4877 |
0.664 |
|
| 2010 |
Hoyer C, Kranaster L, Leweke FM, Klosterkötter J, Meyer-Lindenberg A, Koethe D. Familial differential treatment response in schizophrenia--lessons from a case of three affected siblings. Pharmacopsychiatry. 43: 196-7. PMID 20191444 DOI: 10.1055/s-0030-1248315 |
0.589 |
|
| 2010 |
Guest PC, Wang L, Harris LW, Burling K, Levin Y, Ernst A, Wayland MT, Umrania Y, Herberth M, Koethe D, van Beveren JM, Rothermundt M, McAllister G, Leweke FM, Steiner J, et al. Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patients. Molecular Psychiatry. 15: 118-9. PMID 20098438 DOI: 10.1038/Mp.2009.81 |
0.634 |
|
| 2010 |
Levin Y, Wang L, Schwarz E, Koethe D, Leweke FM, Bahn S. Global proteomic profiling reveals altered proteomic signature in schizophrenia serum. Molecular Psychiatry. 15: 1088-100. PMID 19546861 DOI: 10.1038/Mp.2009.54 |
0.653 |
|
| 2010 |
Herberth M, Krzyszton DN, Koethe D, Craddock MR, Bulger E, Schwarz E, Guest P, Leweke FM, Bahn S. Differential effects on T-cell function following exposure to serum from schizophrenia smokers. Molecular Psychiatry. 15: 364-71. PMID 19002140 DOI: 10.1038/Mp.2008.120 |
0.609 |
|
| 2010 |
Ceccarini J, De Hert M, van Winkel R, Koethe D, Bormans G, Leweke M, Peuskens J, Van Laere K. IN VIVO PET IMAGING OF CEREBRAL TYPE 1 CANNABINOID RECEPTOR AVAILABILITY IN PATIENTS WITH SCHIZOPHRENIA Schizophrenia Research. 117: 170. DOI: 10.1016/J.Schres.2010.02.196 |
0.397 |
|
| 2009 |
Koethe D, Hoyer C, Leweke FM. The endocannabinoid system as a target for modelling psychosis. Psychopharmacology. 206: 551-61. PMID 19529920 DOI: 10.1007/S00213-009-1591-7 |
0.656 |
|
| 2009 |
Koethe D, Giuffrida A, Schreiber D, Hellmich M, Schultze-Lutter F, Ruhrmann S, Klosterkötter J, Piomelli D, Leweke FM. Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis. The British Journal of Psychiatry : the Journal of Mental Science. 194: 371-2. PMID 19336792 DOI: 10.1192/Bjp.Bp.108.053843 |
0.657 |
|
| 2009 |
Schnell T, Koethe D, Daumann J, Gouzoulis-Mayfrank E. The role of cannabis in cognitive functioning of patients with schizophrenia. Psychopharmacology. 205: 45-52. PMID 19326102 DOI: 10.1007/S00213-009-1512-9 |
0.459 |
|
| 2009 |
Koethe D, Kranaster L, Hoyer C, Gross S, Neatby MA, Schultze-Lutter F, Ruhrmann S, Klosterkötter J, Hellmich M, Leweke FM. Binocular depth inversion as a paradigm of reduced visual information processing in prodromal state, antipsychotic-naïve and treated schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 259: 195-202. PMID 19165523 DOI: 10.1007/S00406-008-0851-6 |
0.69 |
|
| 2009 |
Koethe D, Schreiber D, Giuffrida A, Mauss C, Faulhaber J, Heydenreich B, Hellmich M, Graf R, Klosterkötter J, Piomelli D, Leweke FM. Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid. Journal of Neural Transmission (Vienna, Austria : 1996). 116: 301-5. PMID 19137236 DOI: 10.1007/S00702-008-0169-6 |
0.518 |
|
| 2009 |
Koethe D, Kranaster L, Hellmich M, Nolden BM, Klosterkoetter J. P03-156 Oxcarbazepine as an adjunct of antipsychotic therapy in acute schizophrenia: A double-blind, randomised placebo-controlled clinical trial European Psychiatry. 24: 1-1. DOI: 10.1016/S0924-9338(09)71388-4 |
0.451 |
|
| 2009 |
Leweke F, Koethe D, Pahlisch F, Schreiber D, Gerth C, Nolden B, Klosterkötter J, Hellmich M, Piomelli D. Antipsychotic Effects of Cannabidiol European Psychiatry. 24: 1-1. DOI: 10.1016/S0924-9338(09)70440-7 |
0.512 |
|
| 2009 |
Leweke F, Giuffrida A, Pahlisch F, Kranaster L, Hoyer C, Jöpen C, Hellmich M, Klosterkötter J, Piomelli D, Koethe D. Functional Sspects of the Endocannabinoid System in Schizophrenia European Psychiatry. 24: 1-1. DOI: 10.1016/S0924-9338(09)70265-2 |
0.505 |
|
| 2008 |
Schwarz E, Prabakaran S, Whitfield P, Major H, Leweke FM, Koethe D, McKenna P, Bahn S. High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides. Journal of Proteome Research. 7: 4266-77. PMID 18778095 DOI: 10.1021/Pr800188Y |
0.656 |
|
| 2008 |
Koethe D, Bortolato M, Piomelli D, Leweke FM. Improvement of general symptoms in a chronic psychotic patient treated with finasteride: case report. Pharmacopsychiatry. 41: 115-6. PMID 18484553 DOI: 10.1055/S-2008-1058110 |
0.507 |
|
| 2008 |
Leweke FM, Koethe D. Cannabis and psychiatric disorders: it is not only addiction. Addiction Biology. 13: 264-75. PMID 18482435 DOI: 10.1111/J.1369-1600.2008.00106.X |
0.637 |
|
| 2008 |
Huang JT, Wang L, Prabakaran S, Wengenroth M, Lockstone HE, Koethe D, Gerth CW, Gross S, Schreiber D, Lilley K, Wayland M, Oxley D, Leweke FM, Bahn S. Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues. Molecular Psychiatry. 13: 1118-28. PMID 17938634 DOI: 10.1038/Sj.Mp.4002108 |
0.662 |
|
| 2007 |
Huang JT, Leweke FM, Tsang TM, Koethe D, Kranaster L, Gerth CW, Gross S, Schreiber D, Ruhrmann S, Schultze-Lutter F, Klosterkötter J, Holmes E, Bahn S. CSF metabolic and proteomic profiles in patients prodromal for psychosis. Plos One. 2: e756. PMID 17712404 DOI: 10.1371/Journal.Pone.0000756 |
0.675 |
|
| 2007 |
Leweke FM, Giuffrida A, Koethe D, Schreiber D, Nolden BM, Kranaster L, Neatby MA, Schneider M, Gerth CW, Hellmich M, Klosterkötter J, Piomelli D. Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use. Schizophrenia Research. 94: 29-36. PMID 17566707 DOI: 10.1016/J.Schres.2007.04.025 |
0.589 |
|
| 2007 |
Koethe D, Dietl T, Leweke FM, Friess E. Cessation of complex visual hallucinations during treatment with mirtazapine. Pharmacopsychiatry. 40: 82-3. PMID 17447179 DOI: 10.1055/s-2007-961818 |
0.457 |
|
| 2007 |
Koethe D, Llenos IC, Dulay JR, Hoyer C, Torrey EF, Leweke FM, Weis S. Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression. Journal of Neural Transmission (Vienna, Austria : 1996). 114: 1055-63. PMID 17370106 DOI: 10.1007/S00702-007-0660-5 |
0.647 |
|
| 2007 |
Leweke FM, Gerth CW, Koethe D, Nolden BM, Klosterkötter J. [Efficacy and tolerability of quetiapine in hospitalised schizophrenic patients during the acute treatment phase: a PMS study]. Fortschritte Der Neurologie-Psychiatrie. 75: 211-9. PMID 17230308 DOI: 10.1055/s-2006-954962 |
0.527 |
|
| 2007 |
Gross S, Koethe D, Hellmich M, Kranaster L, Hoyer C, Schultze-Lutter F, Klosterkötter J, Leweke F. Binocular depth inversion illusion for early assessment of altered visual information processing in the course of schizophrenia Pharmacopsychiatry. 40. DOI: 10.1055/s-2007-991750 |
0.319 |
|
| 2006 |
Huang JT, Leweke FM, Oxley D, Wang L, Harris N, Koethe D, Gerth CW, Nolden BM, Gross S, Schreiber D, Reed B, Bahn S. Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis. Plos Medicine. 3: e428. PMID 17090210 DOI: 10.1371/Journal.Pmed.0030428 |
0.671 |
|
| 2006 |
Koethe D, Gerth CW, Neatby MA, Haensel A, Thies M, Schneider U, Emrich HM, Klosterkötter J, Schultze-Lutter F, Leweke FM. Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness. Schizophrenia Research. 88: 142-50. PMID 17005373 DOI: 10.1016/J.Schres.2006.07.023 |
0.714 |
|
| 2006 |
Holmes E, Tsang TM, Huang JT, Leweke FM, Koethe D, Gerth CW, Nolden BM, Gross S, Schreiber D, Nicholson JK, Bahn S. Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia. Plos Medicine. 3: e327. PMID 16933966 DOI: 10.1371/Journal.Pmed.0030327 |
0.685 |
|
| 2005 |
Leweke F, Giuffrida A, Koethe D, Nolden B, Gerth C, Schreiber D, Gross S, Juelicher A, Klosterkötter J, Piomelli D. The role of the endogenous cannabinoid system in schizophrenia Pharmacopsychiatry. 38. DOI: 10.1055/s-2005-918765 |
0.39 |
|
| 2004 |
Giuffrida A, Leweke FM, Gerth CW, Schreiber D, Koethe D, Faulhaber J, Klosterkötter J, Piomelli D. Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 2108-14. PMID 15354183 DOI: 10.1038/Sj.Npp.1300558 |
0.659 |
|
| 2004 |
Leweke FM, Gerth CW, Koethe D, Faulhaber J, Klosterkotter J. Oxcarbazepine as an adjunct for schizophrenia. The American Journal of Psychiatry. 161: 1130-1. PMID 15169712 DOI: 10.1176/Appi.Ajp.161.6.1130-A |
0.674 |
|
| 2004 |
Leweke FM, Gerth CW, Koethe D, Klosterkötter J, Ruslanova I, Krivogorsky B, Torrey EF, Yolken RH. Antibodies to infectious agents in individuals with recent onset schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 254: 4-8. PMID 14991372 DOI: 10.1007/S00406-004-0481-6 |
0.62 |
|
| 2003 |
Koethe D, Gerth C, Faulhaber J, Klosterko¨tter J, Leweke F. Adjunctive use of oxcarbazepine in schizophrenia Schizophrenia Research. 60: 290. DOI: 10.1016/S0920-9964(03)80482-6 |
0.484 |
|
| 2003 |
Gerth C, Mauss C, Koethe D, Schultze-Lutter F, Klosterko¨tter J, Leweke F. The natural cannabinoid cannabidiol in the treatment of schizophrenia Schizophrenia Research. 60: 284. DOI: 10.1016/S0920-9964(03)80462-0 |
0.48 |
|
| Show low-probability matches. |